Fritextsökning
Innehållstyper
-
Grönt ljus för Hamlet – startar klinisk studie
Fritt fram för klinisk studie med bröstmjölksprotein mot blåscancer.
-
Framtidens laboratorium i fokus på fackmässan Analytica
Messe München laddar för att återigen ta emot världens laboratoriebransch
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Negativa resultat i ny covidstudie med malariamedel
Ett malariamedel som prövas mot covid-19 gav inte effekt, enligt de första resultaten från en stor placebokontrollerad studie. Samtidigt hissar tidskriften Lanc...
-
Ola Weiland: ”Det är sällan man lyckas med en sån bedrift”
”Alla tre var viktiga och jag tycker det var rätt beslut”, säger Ola Weiland, senior professor i infektionssjukdomar vid Karolinska institutet, om valet av pris...
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Clinical trials in large scale to Stockholm
Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Fewer visitors but satisfied exhibitors
Biotech Forum Scanlab attracted fewer visitors than in 2008. Exhibition manager Bo Rasmussen is content, claiming that the exhibitors are very satisfied.
-
Ny modell ska identifiera rätt dos litium vid bipolär sjukdom
Ny forskning vid Karolinska institutet kan bidra till att lösa ett stort problem inom behandling av bipolär sjukdom: att hitta rätt dos litium för varje patient.
-
Vaccin mot borrelia kan bli verklighet
Franska Valneva, med tillverkning i Sverige, och amerikanska Pfizer inleder en fas III-studie med ett vaccin mot borrelia. Studien startar redan i år.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Changeable proteins cause nerve disease
An incorrectly folded protein is one of the reasons behind the nerve disease ALS, according to new research. But the protein does not have structural errors all...
-
Per Norstedt, Regional Manager, AH Diagnostics
Why are you going to Scanlab+Biotech Forum?
-
A+Science söker vd
Göran Wessman lämnar sitt uppdrag. Bolagets operativa chef kliver in som tillförordnad vd medan rekrytering pågår.
-
Dako appoints new CEO
The Danish cancer therapeutic company Dako has appointed a new CEO after Patrik Dahlén.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Cancerdödande protein förstärks – med hjälp av spindeltråd
Länge har stora förhoppningar knutits till proteinet p53 som behandling mot cancer, men problemet är att kroppens celler tillverkar det i för liten mängd och at...